Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shun Lu

Showing results (431-440 of 661) with videos related to

Pageof 67
Sort By:
Clinical Lung Cancer|February 22, 2025
Efficacy and Safety of Atezolizumab in Chinese Patients With Advanced Thymic Carcinoma: A Multicenter, Single-Arm Phase 2 StudyShun Lu, Xuezhen Ma, Lunxu Liu, et al.
Translational Lung Cancer Research|March 15, 2021
Fruquintinib with gefitinib as first-line therapy in patients carrying EGFR mutations with advanced non-small cell lung cancer: a single-arm, phase II studyShun Lu, Jian-Ying Zhou, Xiao-Min Niu, et al.
Chemico-Biological Interactions|March 10, 2026
Seneciphylline induces hepatotoxicity through mitochondrial apoptosis: mechanistic elucidation and in vitro-to-in vivo prediction via physiologically based pharmacokinetic modeling-facilitated reverse dosimetryYu-Shun Lu, Jiang Ma, Yuan Geng, et al.
Clinical and Translational Radiation Oncology|January 6, 2023
Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapyMinglun Li, Yourong Fan, Christian Trapp, et al.
Clinical and Translational Radiation Oncology|October 9, 2024
Physician reported toxicities and patient reported quality of life of transperineal ultrasound-guided radiotherapy of prostate cancerJing Ma, Paul Rogowski, Christian Trapp, et al.
Cancer Discovery|May 8, 2024
D3S-001, a KRAS G12C Inhibitor with Rapid Target Engagement Kinetics, Overcomes Nucleotide Cycling, and Demonstrates Robust Preclinical and Clinical ActivitiesJing Zhang, Sun Min Lim, Mi Ra Yu, et al.
Frontiers in Immunology|May 11, 2026
Baicalein links macrophage M2 polarization with reduced synovial inflammation to alleviate gouty arthritisMingli Han, Xianshun He, Longfei Han, et al.
Frontiers in Immunology|May 8, 2023
American ginseng with different processing methods ameliorate immunosuppression induced by cyclophosphamide in mice via the MAPK signaling pathwaysYan-Ting Zhang, Wei Tian, Yu-Shun Lu, et al.
Cancer Communications (London, England)|September 28, 2018
Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic responseFeifei Zhang, Wenjie Wang, Yuan Long, et al.
Nature Communications|August 28, 2019
Liquid biopsy-based single-cell metabolic phenotyping of lung cancer patients for informative diagnosticsZiming Li, Zhuo Wang, Yin Tang, et al.
Pageof 67

Showing results (431-440 of 661) with videos related to

Sort By:
Pageof 67
Clinical Lung Cancer|February 22, 2025
Efficacy and Safety of Atezolizumab in Chinese Patients With Advanced Thymic Carcinoma: A Multicenter, Single-Arm Phase 2 StudyShun Lu, Xuezhen Ma, Lunxu Liu, et al.
Translational Lung Cancer Research|March 15, 2021
Fruquintinib with gefitinib as first-line therapy in patients carrying EGFR mutations with advanced non-small cell lung cancer: a single-arm, phase II studyShun Lu, Jian-Ying Zhou, Xiao-Min Niu, et al.
Chemico-Biological Interactions|March 10, 2026
Seneciphylline induces hepatotoxicity through mitochondrial apoptosis: mechanistic elucidation and in vitro-to-in vivo prediction via physiologically based pharmacokinetic modeling-facilitated reverse dosimetryYu-Shun Lu, Jiang Ma, Yuan Geng, et al.
Clinical and Translational Radiation Oncology|January 6, 2023
Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapyMinglun Li, Yourong Fan, Christian Trapp, et al.
Clinical and Translational Radiation Oncology|October 9, 2024
Physician reported toxicities and patient reported quality of life of transperineal ultrasound-guided radiotherapy of prostate cancerJing Ma, Paul Rogowski, Christian Trapp, et al.
Cancer Discovery|May 8, 2024
D3S-001, a KRAS G12C Inhibitor with Rapid Target Engagement Kinetics, Overcomes Nucleotide Cycling, and Demonstrates Robust Preclinical and Clinical ActivitiesJing Zhang, Sun Min Lim, Mi Ra Yu, et al.
Frontiers in Immunology|May 11, 2026
Baicalein links macrophage M2 polarization with reduced synovial inflammation to alleviate gouty arthritisMingli Han, Xianshun He, Longfei Han, et al.
Frontiers in Immunology|May 8, 2023
American ginseng with different processing methods ameliorate immunosuppression induced by cyclophosphamide in mice via the MAPK signaling pathwaysYan-Ting Zhang, Wei Tian, Yu-Shun Lu, et al.
Cancer Communications (London, England)|September 28, 2018
Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic responseFeifei Zhang, Wenjie Wang, Yuan Long, et al.
Nature Communications|August 28, 2019
Liquid biopsy-based single-cell metabolic phenotyping of lung cancer patients for informative diagnosticsZiming Li, Zhuo Wang, Yin Tang, et al.
Pageof 67